The remaining hemostats are used for the treatment of other coagulation factor deficiencies (FI, FX, FXIII) and specific types of bleeding, for example, Lysteda® (tranexamic acid) for cyclic heavy menstrual bleeding and Cyklokapron® (tranexamic acid) for short‐term prevention in hemophilia patients during and after tooth extraction. This evidence concerns the gene F10 and hyperinsulinemic hypoglycemia, familial, 4.